Home  >  Products  >  LGALS14 (lectin, galactoside-binding, soluble, 14) Blocking Peptide (the N terminal of protein) (100ug)
LGALS14 (lectin, galactoside-binding, soluble, 14) Blocking Peptide (the N terminal of protein) (100ug)

LGALS14 (lectin, galactoside-binding, soluble, 14) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-LGALS14 antibody (Catalogue #: ARP42549_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP42549
Size: 100 ug
Weight: 16kDa
Gene: 56891
Format: Lyophilized powder
Target: This gene is predominantly expressed in placenta. The encoded protein belongs to the galectin (galaptin/S-lectin) family. The members of galectin family contain one or two carbohydrate recognition domains, which can bind beta-galactoside. Two alternativel
Alternative names: CLC2; MGC22235; PPL13
See Full Product Listings >